All articles
How to Avoid Gaining Weight After Stopping GLP-1s?
Reading time:
5 min
Weight loss

Get expert guidance and a personalized care plan designed around you.
When to Contact a Doctor About Restarting a GLP-1?
If you notice significant weight regain or struggle to manage your weight without medication, it may be time to consult your healthcare provider. Obesity is a chronic condition that may require ongoing treatment. Talk with your doctor about your options and remember: you are not alone. Your doctor will be able to help assess your situation and determine whether restarting GLP-1s or exploring other weight management options is appropriate.
How Mochi Health Supports Our Patient's Weight Loss Journey
At Mochi Health, we are dedicated to helping you achieve and maintain your weight loss goals. Our approach includes:
Personalized Treatment Plans: We craft individualized plans that align with your unique health needs and lifestyle.
Comprehensive Support: Our team of healthcare providers and dietitians offers guidance and encouragement throughout your journey.
Regular Monitoring: We provide ongoing evaluations to ensure your weight management plan is effective and adjust it as necessary.
Maintaining weight loss after stopping a GLP-1 requires commitment and effort, but with the right strategies and support from Mochi Health, you can achieve lasting success. By focusing on healthy habits and staying informed about your options, you can continue to thrive on your weight management journey. Learn more about if you’re eligible to join Mochi Health today.
References:
Wilding JP, Batterham RL, Calanna S, et al.: Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021, 384:989-1002. https://www.nejm.org/doi/10.1056/NEJMoa2032183
Food and Drug Administration. GLP-1 (semaglutide) injection prescribing information, revised 2020. https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/209637s003lbl.pdf
Wilding JPH, Batterham RL, Davies M, Van Gaal LF, Kandler K, Konakli K, Lingvay I, McGowan BM, Oral TK, Rosenstock J, Wadden TA, Wharton S, Yokote K, Kushner RF; STEP 1 Study Group. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes Obes Metab. 2022 Aug;24(8):1553-1564. doi: 10.1111/dom.14725. Epub 2022 May 19. PMID: 35441470; PMCID: PMC9542252. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542252/
Share this post
Weight loss
More articles
















